Merck & Co. sales fell 4% to $ 10.5 billion in the third quarter and profit tumbled 20% as the Whitehouse Station, N.J.-based drugmaker faced declining sales of some of its top-selling drugs and the loss of market exclusivity for others, the company…
Modern Healthcare Breaking News
Merck sees weaker Q3 on divestitures, hepatitis drug competition
Monday, October 27, 2014
Merck sees weaker Q3 on divestitures, hepatitis drug competition
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment